Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

BWAY stock hub

BrainsWay Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BWAYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

694.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BWAY

In the news

Latest news · BWAY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E56.5

P25 12.3P50 18.4P75 33.1

Trailing P/E91.7

P25 14.9P50 23.2P75 38.5

ROE11.2

P25 -105.6P50 -46.5P75 -3.1

ROIC45.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BWAY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

USD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001076643
Company name	BrainsWay Ltd.
Country	Israel
Country code	US
Cusip	10501L106
Employees	129
Employees Change	9%
Employees Change Percent	7.5
Enterprise value	$627.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2019-04-17
Isin	US10501L1061
Last refreshed	2026-05-10
Market cap	$694.7M
Market cap category	Small-Cap
Price	$17.17
Price currency	USD
Rev Per Employee	404,844.96x
Sector	Healthcare
Sic	7389
Symbol	BWAY
Website	https://www.brainsway.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.09%
EV Earnings	82.87x
EV Sales Forward	2.93x
EV/EBIT	145.21x
EV/EBITDA	122.7x
EV/FCF	41.44x
EV/Sales	12.02x
FCF yield	2.18%
Forward P/E	56.5x
P/B ratio	9.5x
P/E ratio	91.71x
P/S ratio	13.3x
PS Forward	3.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.28%
EBITDA Margin	9.8%
FCF margin	29.01%
Gross margin	75.42%
Gross Profit	$39.4M
Gross Profit Growth	28.79%
Gross Profit Growth Q	30.63%
Gross Profit Growth3 Y	25.24%
Gross Profit Growth5 Y	18.3%
Net Income	$7.6M
Net Income Growth	159.33%
Net Income Growth Q	85.72%
Net Income Growth Quarters	11%
Net Income Growth Years	3%
Pretax Margin	14.76%
Profit Margin	14.5%
Profit Per Employee	$58,721
Profitable Years	2
ROA	2.6
Roa5y	-3.63
ROCE	4.77
ROE	11.18
Roe5y	-7.13
ROIC	45.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	294.63%
Cagr3y	183.16%
Cagr5y	31.83%
EPS Growth	229.1
EPS Growth Q	321.2
EPS Growth Quarters	3
EPS Growth Years	3
FCF Growth	132.9%
OCF Growth	69.82%
Revenue Growth	27.33x
Revenue Growth Q	27.43x
Revenue Growth Quarters	10x
Revenue Growth Years	3x
Revenue Growth3 Y	24.33x
Revenue Growth5 Y	18.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.5
Assets	$113.2M
Cash	$67.7M
Current Assets	$83.8M
Current Liabilities	$22.5M
Debt	$6.8M
Debt EBITDA	$1.16
Debt Equity	$0.09
Debt FCF	$0.45
Equity	$73.2M
Interest Coverage	2.77
Liabilities	$40M
Long Term Assets	$29.4M
Long Term Liabilities	$17.5M
Net Cash	$60.9M
Net Cash By Market Cap	$8.76
Net Cash Growth	-4.45%
Net Debt EBITDA	$-11.9
Net Debt Equity	$-0.83
Net Debt FCF	$-4.02
Tangible Book Value	$73.2M
Tangible Book Value Per Share	$1.87
WACC	5.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.73
Inventory Turnover	2.35
Net Working Capital	$-5.3M
Quick ratio	3.23
Working Capital	$61.3M
Working Capital Turnover	$0.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.91%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	294.26%
200-day SMA	10.13
3Y total return	2,171.92%
50-day SMA	14.29
50-day SMA vs 200-day SMA	50over200
5Y total return	298.04%
All Time High	17.26
All Time High Change	-0.52%
All Time High Date	2026-05-08
All Time Low	0.69
All Time Low Change	2,388.41%
All Time Low Date	2023-05-11
ATR	0.66
Beta	0.22
Ch YTD	80.55
High	17.26
High52	17.26
High52 Date	2026-05-08
High52ch	-0.52%
Low	16.79
Low52	4.31
Low52 Date	2025-05-12
Low52ch	298.84%
Ma50ch	20.13%
Price vs 200-day SMA	69.45%
RSI	67.48
RSI Monthly	89.01
RSI Weekly	81.39
Sharpe ratio	2.79x
Sortino ratio	5.45
Total Return	-13.91%
Tr YTD	80.55
Tr1m	40.05%
Tr1w	1.96%
Tr3m	57.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$0.05
Earnings EPS Estimate Growth	400
Earnings Revenue Estimate	14,539,336x
Earnings Revenue Estimate Growth	26.03x
Operating Income	$4.3M
Operating Income Growth	210.8
Operating Income Growth Q	344.5
Operating margin	8.28
Price target	$13.25
Price Target Change	$-22.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,875,255%
Float Percent	69.63%
Net Borrowing	-832,000
Shares Insiders	17.08%
Shares Institutions	22.32%
Shares Out	40,033,026
Shares Qo Q	7.02%
Shares Yo Y	13.91%
Short Ratio	0.57
Short Shares	0.33

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$14M
Average Volume	114,066.7x
Bv Per Share	1.87
CAPEX	$-2.3M
Ch1m	40.05
Ch1w	1.96
Ch1y	294.3
Ch3m	57.67
Ch3y	2,171.8
Ch5y	298
Ch6m	120.3
Change	2.75%
Change From Open	0.35
Close	16.71
Days Gap	2.39
Depreciation Amortization	793,000
Dollar Volume	1,606,648.4
Earnings Date	2026-05-13
Earnings Time	bmo
EBIT	$4.3M
EBITDA	$5.1M
EPS	$0.18
F Score	5
FCF	$15.1M
FCF EV Yield	2.41x
FCF Per Share	$0.38
Financing CF	-1,709,000
Fiscal Year End	December
Founded	2,003
Graham Number	2.76002
Graham Upside	-83.93
Income Tax	$135,000
Investing CF	-17,466,000
Ipr	56.09
Iprfo	208.3
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-03-11
Last Report Date	2025-12-31
Last Split Date	2026-03-04
Last Split Type	Forward
Last10k Filing Date	2001-07-05
Ma150	11.13
Ma150ch	54.21%
Ma20	16.02
Ma20ch	7.21%
Net CF	-1,645,000
Next Earnings Date	2026-05-13
Open	17.11
Optionable	Yes
P FCF Ratio	45.86
P OCF Ratio	39.72
Position In Range	80.85
Post Close	17.17
Postmarket Change Percent	-0.41
Postmarket Price	$17.1
Ppne	12,780,000
Price Date	2026-05-08
Price EBITDA	$136
Ptbv Ratio	9.5
Relative Volume	0.82x
Revenue	52,225,000x
SBC By Revenue	2.29x
Share Based Comp	1,196,000
Tax By Revenue	0.26x
Tax Rate	1.75%
Tr6m	120.27%
Volume	93,573
Z Score	3.73

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BWAY pay a dividend?

Capital-return profile for this ticker.

Performance

BWAY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BWAY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.3%

Float: +69.6% of shares outstanding

Insider ownership

+17.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BWAY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.5

Neutral momentum band

Price vs 200-day MA

+69.4%

50/200-day relationship not available

Beta (5Y)

0.22

Less volatile than the market

Sharpe ratio

2.79

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BWAY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BWAY stock rating?

BrainsWay Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BWAY analysis?

The full report lives at /stocks/BWAY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BWAY?

The latest report frames BWAY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BWAY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.